Back to top

Image: Bigstock

Should You Buy Graphite Bio (GRPH) Ahead of Earnings?

Read MoreHide Full Article

Investors are always looking for stocks that are poised to beat at earnings season and Graphite Bio (GRPH - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.

That is because Graphite Bio is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good indicator of some favorable trends underneath the surface for GRPH in this report.

In fact, the Most Accurate Estimate for the current quarter is currently at a loss of 28 cents per share for GRPH, compared to a broader Zacks Consensus Estimate of a loss of 30 cents per share. This suggests that analysts have very recently bumped up their estimates for GRPH, giving the stock a Zacks Earnings ESP of +6.67% heading into earnings season.

Graphite Bio, Inc. Price and EPS Surprise

Graphite Bio, Inc. Price and EPS Surprise

Graphite Bio, Inc. price-eps-surprise | Graphite Bio, Inc. Quote

Why is this Important?

A positive reading for the Zacks Earnings ESP has proven to be very powerful in producing both positive surprises, and outperforming the market. Our recent 10-year backtest shows that stocks that have a positive Earnings ESP and a Zacks Rank #3 (Hold) or better show a positive surprise nearly 70% of the time, and have returned over 28% on average in annual returns (see more Top Earnings ESP stocks here).

Given that GRPH has a Zacks Rank #3 and an ESP in positive territory, investors might want to consider this stock ahead of earnings. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Clearly, recent earnings estimate revisions suggest that good things are ahead for Graphite Bio, and that a beat might be in the cards for the upcoming report.

See More Zacks Research for These Tickers

Normally $25 each - click below to receive one report FREE:

Graphite Bio, Inc. (GRPH) - free report >>

Published in